Immunomodulatory compounds and methods of use thereof
The present invention is directed to methods of treating diseases and disorders related to immune responses by administering one or more immunomodulatory compounds. In particular, the invention is directed to methods of stimulating and reducing immune responses, treating autoimmune conditions, treating allergic reactions and asthma, and preventing ischemic damage and asthma by administering one or more immunomodulatory compounds.
1. A method of inducing or stimulating an immune response in a subject in need thereof comprising administering an effective amount of a compound of the formula II, as the active ingredient:
wherein:
R 1 is selected from the group consisting of
(a) C(O);
(b) C(O)—C 1-14 alkyl-C(O), wherein said C 1-14 alkyl is optionally substituted with hydroxy, C 1-5 alkoxy, C 1-5 alkylenedioxy, C 1-5 alkylamino, or C 1-5 -alkyl-aryl, wherein said aryl moiety of said C 1-5 -alkyl-aryl is optionally substituted with C 1-5 alkoxy, C 1-5 alkyl amino, C 1-5 alkoxy-amino, C 1-5 alkylamino-C 1-5 alkoxy, —O—C 1-5 alkylamino-C 1-5 alkoxy, —O—C 1-5 alkylamino-C(O)—C 1-5 alkyl C(O)OH, —O—C 1-5 alkylamino-C(O)—C 1-5 alkyl-C(O)—C 1-5 alkyl;
(c) C 2 to C 15 straight or branched chain alkyl optionally substituted with hydroxy or alkoxy; and
(d) —C(O)—C 6-12 arylene-C(O)— wherein said arylene is optionally substituted with hydroxy, halogen, nitro or amino;
a and b are independently 0, 1, 2, 3 or 4;
d, d′, d″, e, e′ and e″ are independently an integer from 1 to 4;
X 1 , X 2 , Y 1 and Y 2 are independently selected from the group consisting of null, oxygen, NH and N(C(O)C 1-4 alkyl), and N(C 1-4 alkyl) 2 ;
W 1 and W 2 are independently selected from the group consisting of carbonyl, methylene, sulfone and sulfoxide;
R 2 and R 5 are independently selected from the group consisting of:
(a) C 2 to C 20 straight chain or branched chain alkyl which is optionally substituted with oxo, hydroxy or alkoxy,
(b) C 2 to C 20 straight chain or branched chain alkenyl or dialkenyl which is optionally substituted with oxo, hydroxy or alkoxy;
(c) C 2 to C 20 straight chain or branched chain alkoxy which is optionally substituted with oxo, hydroxy or alkoxy;
(d) —NH—C 2 to C 20 straight chain or branched chain alkyl, wherein said alkyl group is optionally substituted with oxo, hydroxy or alkoxy; and
wherein Z is selected from the group consisting of O and NH, and M and N are independently selected from the group consisting of C 2 to C 20 straight chain or branched chain alkyl, alkenyl, alkoxy, acyloxy, alkylamino, and acylamino;
R 3 and R 6 are independently selected from the group consisting of C 2 to C 20 straight chain or branched chain alkyl or alkenyl optionally substituted with oxo or fluoro;
R 4 and R 7 are independently selected from the group consisting of C(O)C 2 to C 20 straight chain or branched chain alkyl or alkenyl; C 2 to C 20 straight chain or branched chain alkyl; C 2 to C 20 straight chain or branched chain alkoxy;
C 2 to C 20 straight chain or branched chain alkenyl; wherein said alkyl, alkenyl or alkoxy groups can be independently and optionally substituted with hydroxy, fluoro or C 1 to C 5 alkoxy;
G 1 , G 2 , G 3 and G 4 are independently selected from the group consisting of oxygen, methylene, amino, thiol, —NHC(O)—, and —N(C(O)C 1-4 alkyl)-;
or G 2 R 4 or G 4 R 7 may together be a hydrogen atom or hydroxyl;
a′ and b′ are independently 2, 3, 4, 5, 6, 7, or 8;
Z 1 is selected from the group consisting of —OP(O)(OH) 2 , —P(O)(OH) 2 , —OP(O)(OR 8 )(OH) where R 8 is a C 1 -C 4 alkyl chain, —OS(O) 2 OH, —S(O) 2 OH—, —CO 2 H, —OB(OH) 2 , —OH, —CH 3 , —NH 2 , NR 9 3 where R 9 is a C 1 -C 4 alkyl chain;
Z 2 is —OP(O)(OH) 2 , —P(O)(OH) 2 ′, —OP(O)(OR 10 )(OH) where R 10 is a C 1 -C 4 alkyl chain, —OS(O) 2 OH, —S(O) 2 OH, CO 2 H, —OB(OH) 2 , —OH, CH 3 , —NH 2 , —NR 11 , where R 11 is a C 1 -C 4 alkyl chain;
or a pharmaceutically acceptable salt thereof.
2. The method of claim 1 , wherein the subject is a human.
3. The method of claim 1 , wherein the subject is a mammal, fish, or reptile.
4. A method for upregulation of the immune system in a subject in need thereof comprising administering a therapeutically effective amount of a compound of formula II,
wherein:
R 1 is selected from the group consisting of
(a) C(O);
(b) C(O)—C 1-14 alkyl-C(O), wherein said C 1-14 alkyl is optionally substituted with hydroxy, C 1-5 alkoxy, C 1-5 alkylenedioxy, C 1-5 alkylamino, or C 1-5 -alkyl-aryl, wherein said aryl moiety of said C 1-5 -alkyl-aryl is optionally substituted with C 1-5 alkoxy, C 1-5 alkyl amino, C 1-5 alkoxy-amino, C 1-5 alkylamino-C 1-5 alkoxy, —O—C 1-5 alkylamino-C 1-5 alkoxy, —O—C 1-5 alkylamino-C(O)—C 1-5 alkyl C(O)OH, —O—C 1-5 alkylamino-C(O)—C 1-5 alkyl-C(O)—C 1-5 alkyl;
(c) C 2 to C 15 straight or branched chain alkyl optionally substituted with hydroxy or alkoxy; and
(d) —C(O)—C 6-12 arylene-C(O)—wherein said arylene is optionally substituted with hydroxy, halogen, nitro or amino;
a and b are independently 0, 1, 2, 3 or 4;
d, d′, d″, e, e′ and e″ are independently an integer from 1 to 4;
X 1 , X 2 , Y 1 and Y 2 are independently selected from the group consisting of null, oxygen, NH and N(C(O)C 1-4 alkyl), and N(C 1-4 alkyl) 2 ;
W 1 and W 2 are independently selected from the group consisting of carbonyl, methylene, sulfone and sulfoxide;
R 2 and R 5 are independently selected from the group consisting of:
(a) C 2 to C 20 straight chain or branched chain alkyl which is optionally substituted with oxo, hydroxy or alkoxy,
(b) C 2 to C 20 straight chain or branched chain alkenyl or dialkenyl which is optionally substituted with oxo, hydroxy or alkoxy;
(c) C 2 to C 20 straight chain or branched chain alkoxy which is optionally substituted with oxo, hydroxy or alkoxy;
(d) —NH—C 2 to C 20 straight chain or branched chain alkyl, wherein said alkyl group is optionally substituted with oxo, hydroxy or alkoxy; and
wherein Z is selected from the group consisting of O and NH, and M and N are independently selected from the group consisting of C 2 to C 20 straight chain or branched chain alkyl, alkenyl, alkoxy, acyloxy, alkylamino, and acylamino;
R 3 and R 6 are independently selected from the group consisting of C 2 to C 20 straight chain or branched chain alkyl or alkenyl optionally substituted with oxo or fluoro;
R 4 and R 7 are independently selected from the group consisting of C( 0 )C 2 to C 20 straight chain or branched chain alkyl or alkenyl; C 2 to C 20 straight chain or branched chain alkyl;
C 2 to C 20 straight chain or branched chain alkoxy; C 2 to C 20 straight chain or branched chain alkenyl; wherein said alkyl, alkenyl or alkoxy groups can be independently and optionally substituted with hydroxy, fluoro or C 1 to C 5 alkoxy;
G 1 , G 2 , G 3 and G 4 are independently selected from the group consisting of oxygen, methylene, amino, thiol, —NHC(O)—, and —N(C(O)C 1-4 alkyl)-; or
G 2 R 4 or G 4 R 7 may together be a hydrogen atom or hydroxyl;
a′ and b′ are independently 2, 3, 4, 5, 6, 7, or 8;
Z 1 is selected from the group consisting of —OP(O)(OH) 2 , —P(O)(OH) 2 , —OP(O)(OR 8 )(OH) where R 8 is a C 1 -C 4 alkyl chain, —OS(O) 2 OH, —S(O) 2 OH—, —CO 2 H, —OB(OH) 2 , —OH, —CH 3 , —NH 2 , NR 9 3 where R 9 is a C 1 -C 4 alkyl chain;
Z 2 is —OP(O)(OH) 2 , —P(O)(OH) 2 ′, —OP(O)(OR 10 )(OH) where R 1 ° is a C 1 -C 4 alkyl chain, —OS(O) 2 OH, —S(O) 2 OH, CO 2 H, —OB(OH) 2 , —OH, CH 3 , —NH 2 , —NR 11 , where R 11 is a C 1 -C 4 alkyl chain;
or a pharmaceutically acceptable salt thereof,
wherein said compound has immunostimulatory activity.
5. The method of claim 1 , wherein a′ and b′ of Formula II are both 2.
6. The method of claim 4 , wherein a′ and b′ of Formula II are both 2.
7. A method of inducing or stimulating an immune response in a subject in need thereof comprising administering an effective amount of a compound of formula I, as the active ingredient:
wherein:
R 1 is selected from the group consisting of
(a) C(O);
(b) C(O)—C 2-15 alkyl-C(O) optionally substituted with hydroxy or alkoxy;
(c) C 2 to C 15 straight or branched chain alkyl optionally substituted with hydroxy or alkoxy;
a and b are independently 2, 3, or 4;
d and e are independently an integer from 1 to 4;
d′ and e′ are 1;
d″ and e″ are 2;
X 1 and Y 1 are NH;
X 2 and Y 2 are independently selected from the group consisting of oxygen and NH;
W 1 and W 2 are carbonyl;
R 2 and R 5 are independently selected from the group consisting of:
(a) C 2 to C 20 straight chain or branched chain alkyl which is optionally substituted with hydroxy or alkoxy,
(b) C 2 to C 20 straight chain or branched chain alkenyl which is optionally substituted with hydroxy or alkoxy;
(c) CH 2 -alkyl carbonyl;
(d) CH 2 -alkenyl carbonyl; and
wherein Z is selected from the group consisting of O and NH, and M and N are independently selected from the group consisting of C 2 to C 20 straight chain or branched chain alkyl, alkenyl, alkoxy, acyloxy, alkylamino, and acylamino;
R 3 and R 6 are independently selected from the group consisting of C 2 to C 20 straight chain or branched chain alkyl or alkenyl;
R 4 and R 7 are independently selected from the group consisting of hydrogen, C 2 to C 20 straight chain or branched chain alkyl or alkenyl; C 2 to C 20 straight chain or branched chain alkyl carbonyl; and C 2 to C 20 straight chain or branched chain alkenyl carbonyl, optionally substituted with hydroxy or alkoxy; and
G 1 , G 2 , G 3 , and G 4 are oxygen;
or a pharmaceutically acceptable salt thereof.
8. The method of claim 7 , wherein the subject is a human.
9. The method of claim 7 , wherein the subject is a mammal, fish, or reptile.
10. A method for upregulation of the immune system in a subject in need thereof comprising administering a therapeutically effective amount of a compound of formula I,
wherein:
R 1 is selected from the group consisting of
(a) C(O);
(b) C(O)—C 2-15 alkyl-C(O) optionally substituted with hydroxy or alkoxy;
(c) C 2 to C 15 straight or branched chain alkyl optionally substituted with hydroxy or alkoxy;
a and b are independently 2, 3, or 4;
d and e are independently an integer from 1 to 4;
d′ and e′ are 1;
d″ and e″ are 2;
X 1 and Y 1 are NH;
X 2 and Y 2 are independently selected from the group consisting of oxygen and NH;
W 1 and W 2 are carbonyl;
R 2 and R 5 are independently selected from the group consisting of:
(a) C 2 to C 20 straight chain or branched chain alkyl which is optionally substituted with hydroxy or alkoxy,
(b) C 2 to C 20 straight chain or branched chain alkenyl which is optionally substituted with hydroxy or alkoxy;
(c) CH 2 -alkyl carbonyl;
(d) CH 2 -alkenyl carbonyl; and
wherein Z is selected from the group consisting of O and NH, and M and N are independently selected from the group consisting of C 2 to C 20 straight chain or branched chain alkyl, alkenyl, alkoxy, acyloxy, alkylamino, and acylamino;
R 3 and R 6 are independently selected from the group consisting of C 2 to C 20 straight chain or branched chain alkyl or alkenyl;
R 4 and R 7 are independently selected from the group consisting of hydrogen, C 2 to C 20 straight chain or branched chain alkyl or alkenyl; C 2 to C 20 straight chain or branched chain alkyl carbonyl; and C 2 to C 20 straight chain or branched chain alkenyl carbonyl, optionally substituted with hydroxy or alkoxy; and
G 1 , G 2 , G 3 , and G 4 are oxygen;
or a pharmaceutically acceptable salt thereof;
wherein said compound has immunostimulatory activity.
11. The method of claim 10 , wherein the subject is a human.
12. The method of claim 10 , wherein the subject is a mammal, fish, or reptile.